US 10577368
A3 adenosine receptor agonists
granted A61PA61P29/00A61P35/00
Quick answer
US patent 10577368 (A3 adenosine receptor agonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P29/00, A61P35/00